See more : Jiutian Chemical Group Limited (C8R.SI) Income Statement Analysis – Financial Results
Complete financial analysis of Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jilin Jian Yisheng Pharmaceutical Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Gold Royalty Corp. (GROY-WT) Income Statement Analysis – Financial Results
- Amcor plc (AMCCF) Income Statement Analysis – Financial Results
- Shirai Electronics Industrial Co., Ltd. (6658.T) Income Statement Analysis – Financial Results
- DFM Foods Limited (DFMFOODS.NS) Income Statement Analysis – Financial Results
- Doubleview Gold Corp. (DBLVF) Income Statement Analysis – Financial Results
Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
About Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Jilin Jian Yisheng Pharmaceutical Co., Ltd. manufactures and sells medicine, Chinese herbal medicine, cosmetics, and food products in China. It offers capsules, injections, tablets, granules, and other products; and Ginseng medicinal and bee products. Jilin Jian Yisheng Pharmaceutical Co., Ltd. was founded in 1997 and is based in Ji'an, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 853.66M | 830.04M | 877.93M | 842.59M | 1.01B | 975.09M | 1.03B | 939.01M | 819.60M | 787.89M | 643.90M | 600.50M | 528.93M | 516.22M | 414.88M | 311.75M | 267.84M | 226.37M |
| Cost of Revenue | 224.20M | 216.53M | 220.54M | 214.70M | 249.51M | 222.84M | 268.65M | 249.10M | 217.40M | 252.65M | 169.28M | 183.90M | 134.40M | 124.96M | 104.51M | 73.86M | 69.73M | 64.87M |
| Gross Profit | 629.46M | 613.52M | 657.39M | 627.89M | 763.24M | 752.25M | 765.79M | 689.91M | 602.20M | 535.24M | 474.62M | 416.60M | 394.52M | 391.27M | 310.38M | 237.89M | 198.11M | 161.50M |
| Gross Profit Ratio | 73.74% | 73.91% | 74.88% | 74.52% | 75.36% | 77.15% | 74.03% | 73.47% | 73.48% | 67.93% | 73.71% | 69.38% | 74.59% | 75.79% | 74.81% | 76.31% | 73.96% | 71.34% |
| Research & Development | 18.68M | 18.78M | 20.89M | 15.71M | 19.47M | 19.53M | 19.66M | 17.53M | 15.19M | 27.79M | 28.64M | 11.05M | 0.00 | 0.00 | 0.00 | 7.57M | 6.38M | 5.95M |
| General & Administrative | 30.72M | 33.86M | 32.38M | 36.32M | 30.73M | 30.28M | 23.92M | 26.48M | 31.18M | 67.46M | 62.22M | 22.45M | 69.68M | 49.43M | 43.04M | 15.59M | 14.26M | 12.78M |
| Selling & Marketing | 294.78M | 388.92M | 414.71M | 402.57M | 512.49M | 520.62M | 532.12M | 517.81M | 452.83M | 363.29M | 338.61M | 277.56M | 224.61M | 235.45M | 191.82M | 142.44M | 114.86M | 95.67M |
| SG&A | 489.14M | 422.79M | 447.09M | 438.89M | 543.22M | 550.90M | 556.04M | 544.29M | 484.01M | 430.74M | 400.83M | 300.01M | 294.29M | 284.88M | 234.86M | 158.03M | 129.12M | 108.46M |
| Other Expenses | 5.92M | 63.99M | 56.76M | 44.56M | 52.32M | -6.57M | -3.32M | 22.74M | 11.69M | 13.60M | 20.91M | -5.32M | -15.30M | 4.60M | 1.42M | -261.88K | 130.83K | -41.98K |
| Operating Expenses | 513.73M | 505.55M | 524.74M | 499.16M | 615.02M | 605.41M | 619.22M | 614.86M | 549.05M | 441.45M | 411.96M | 345.18M | 302.03M | 291.15M | 240.39M | 182.20M | 150.52M | 125.58M |
| Cost & Expenses | 737.93M | 722.08M | 745.27M | 713.86M | 864.53M | 828.25M | 887.87M | 863.96M | 766.45M | 694.11M | 581.23M | 529.09M | 436.44M | 416.11M | 344.89M | 256.06M | 220.25M | 190.45M |
| Interest Income | 14.67M | 8.20M | 9.19M | 3.28M | 303.52K | 562.27K | 1.56M | 1.59M | 2.77M | 3.10M | 13.57M | 26.78M | 21.84M | 200.04K | 157.86K | 75.84K | -0.55 | -0.17 |
| Interest Expense | 13.78M | 14.03M | 13.36M | 13.10M | 17.01M | 22.64M | 27.97M | 35.29M | 39.42M | 12.31M | 419.37K | 1.91M | 651.71K | 1.13M | 2.15M | 4.72M | 4.16M | 172.41K |
| Depreciation & Amortization | 50.46M | 45.19M | 44.27M | 41.10M | 42.72M | 40.80M | 40.95M | 31.61M | 24.04M | 23.23M | 18.60M | 21.64M | 18.11M | 15.41M | 11.82M | 10.88M | 6.74M | 2.76M |
| EBITDA | 176.00M | 160.54M | 179.82M | 159.54M | 167.57M | 163.69M | 166.74M | 97.48M | 78.81M | 146.89M | 121.46M | 138.01M | 131.72M | 119.37M | 82.46M | 65.54M | 53.97M | 38.56M |
| EBITDA Ratio | 20.62% | 19.50% | 20.45% | 19.90% | 18.56% | 18.55% | 17.82% | 13.86% | 11.19% | 18.59% | 18.95% | 23.11% | 26.09% | 23.19% | 20.08% | 21.27% | 19.46% | 18.04% |
| Operating Income | 115.73M | 102.66M | 128.63M | 109.74M | 111.00M | 106.70M | 101.03M | 8.04M | 3.69M | 98.41M | 81.68M | 95.46M | 107.29M | 98.21M | 67.07M | 50.20M | 46.44M | 33.92M |
| Operating Income Ratio | 13.56% | 12.37% | 14.65% | 13.02% | 10.96% | 10.94% | 9.77% | 0.86% | 0.45% | 12.49% | 12.69% | 15.90% | 20.28% | 19.02% | 16.17% | 16.10% | 17.34% | 14.98% |
| Total Other Income/Expenses | -3.97M | -1.44M | -5.26M | -4.70M | -2.88M | -6.57M | -3.32M | -11.34M | -24.93M | 11.88M | 20.76M | 19.13M | 5.67M | 4.60M | 1.42M | -4.92M | -587.64K | -358.71K |
| Income Before Tax | 111.76M | 101.23M | 123.37M | 105.04M | 108.11M | 100.13M | 97.70M | 30.46M | 15.35M | 110.29M | 102.44M | 114.58M | 112.96M | 102.81M | 68.49M | 49.94M | 45.86M | 33.56M |
| Income Before Tax Ratio | 13.09% | 12.20% | 14.05% | 12.47% | 10.68% | 10.27% | 9.44% | 3.24% | 1.87% | 14.00% | 15.91% | 19.08% | 21.36% | 19.92% | 16.51% | 16.02% | 17.12% | 14.82% |
| Income Tax Expense | 15.65M | 12.91M | 18.67M | 15.42M | 15.78M | 15.22M | 14.90M | 13.70M | 4.83M | 13.97M | 14.94M | 17.28M | 16.17M | 15.21M | 7.39M | 8.58M | 9.75M | 10.09M |
| Net Income | 94.73M | 83.10M | 96.02M | 80.06M | 76.60M | 69.08M | 60.07M | 13.19M | 10.91M | 96.41M | 87.32M | 96.63M | 96.48M | 87.64M | 61.13M | 41.37M | 36.11M | 23.47M |
| Net Income Ratio | 11.10% | 10.01% | 10.94% | 9.50% | 7.56% | 7.08% | 5.81% | 1.41% | 1.33% | 12.24% | 13.56% | 16.09% | 18.24% | 16.98% | 14.73% | 13.27% | 13.48% | 10.37% |
| EPS | 0.29 | 0.25 | 0.29 | 0.24 | 0.23 | 0.21 | 0.18 | 0.04 | 0.03 | 0.29 | 0.26 | 0.29 | 0.31 | 0.35 | 0.25 | 0.17 | 0.15 | 0.09 |
| EPS Diluted | 0.29 | 0.25 | 0.29 | 0.24 | 0.23 | 0.21 | 0.18 | 0.04 | 0.03 | 0.29 | 0.26 | 0.29 | 0.31 | 0.35 | 0.25 | 0.17 | 0.15 | 0.09 |
| Weighted Avg Shares Out | 330.95M | 330.95M | 330.95M | 330.95M | 330.95M | 330.95M | 330.95M | 330.69M | 330.65M | 332.44M | 335.84M | 329.41M | 307.93M | 248.03M | 247.82M | 248.20M | 248.20M | 248.20M |
| Weighted Avg Shares Out (Dil) | 330.95M | 330.95M | 330.95M | 330.95M | 330.95M | 331.00M | 330.96M | 330.69M | 330.65M | 332.44M | 335.84M | 329.41M | 307.93M | 248.03M | 247.82M | 248.20M | 248.20M | 248.20M |
No news found for: 002566.SZ
Source: https://incomestatements.info
Category: Stock Reports